Financial Overview and Key Operating Metrics

Financial and operating metrics, which include non-GAAP financial measures, include:

FutureFuel Corp.

Certain Financial and Operating Metrics

(Dollars in thousands, except per share amounts)

(Unaudited)
         
  Three Months Ended Three Months Ended     
  September 30, 2013 September 30, 2012 Dollar Change % Change
Revenues  $ 121,119  $ 88,276  $ 32,843 37.2%
Income from operations  $ 23,515  $ 19,181  $ 4,334 22.6%
Net income  $ 15,297  $ 12,549  $ 2,748 21.9%
Earnings per common share – basic  $ 0.35  $ 0.30  $ 0.05 16.7%
Earnings per common share – diluted  $ 0.35  $ 0.30  $ 0.05 16.7%
Capital expenditures (net of reimbursements)  $ 7,570  $ 2,656  $ 4,914 185.0%
Adjusted EBITDA  $ 28,177  $ 23,991  $ 4,186 17.4%
         
         
  Nine Months Ended Nine Months Ended    
  September 30, 2013 September 30, 2012 Dollar Change % Change
Revenues  $ 319,347  $ 277,240  $ 42,107 15.2%
Income from operations  $ 67,440  $ 41,336  $ 26,104 63.2%
Net income  $ 47,503  $ 28,135  $ 19,368 68.8%
Earnings per common share - basic  $ 1.10  $ 0.68  $ 0.42 61.8%
Earnings per common share – diluted  $ 1.10  $ 0.68  $ 0.42 61.8%
Capital expenditures (net of customer reimbursements and grants)  $ 11,179  $ 6,435  $ 4,744 73.7%
Adjusted EBITDA  $ 71,251  $ 46,515  $ 24,736 53.2%

Third Quarter Financial and Business Summary

Revenues for the three months ended September 30, 2013 were $121,119,000 as compared to revenues for the three months ended September 30, 2012 of $88,276,000, an increase of 37%. Revenues from biofuels were up 61% and accounted for 64% of total revenues in the third quarter of 2013 as compared to 54% in the third quarter of 2012. Revenues from chemicals increased 8% and accounted for 36% of total revenues in the third quarter of 2013 as compared to 46% in the third quarter of 2012. Within the chemicals segment, revenues for the three months ended September 30, 2013 changed as follows compared to the three months ended September 30, 2012: (i) revenues from other custom chemicals increased 47%; (ii) revenues from the industrial intermediate utilized in the antimicrobial industry increased 39%; (iii) revenues from other performance chemicals increased 23% (iv) revenues from CPOs increased 27%; (v) revenues from DIPB decreased 25%; and (vi) revenues from the proprietary herbicide and intermediates decreased 25%.  Revenues from the bleach activator were unchanged.

If you liked this article you might like

Future Fuel, Premier, Sturm Ruger: 3 Bargain Stocks Private Equity Should Grab

Here are 3 Stocks That Private Equity Would Consider Bargains

Is FutureFuel Corp. Ready to Hit the Gas?

Is FutureFuel Corp. Ready to Hit the Gas?

Is FutureFuel Corp. Ready to Hit the Gas?

Is FutureFuel Corp. Ready to Hit the Gas?

5 Stocks Poised for Big Breakouts